Specialism
HealthcareProPharma Group, a leading provider of compliance services, continues to expand its global presence, now with more than 1,100 employees across United States, Canada, Europe, Japan, and Australia. "The addition of Southwood Research's deep scientific expertise emphasizes ProPharma Group's commitment to providing industry leading regulatory support to our clients. ProPharma Group's robust regulatory capabilities, bolstered by the recent additions of The Weinberg Group in the United States and now Southwood Research in the UK, represent a truly unique end - to end global regulatory practice," said Dawn Sherman, ProPharma Groups's CEO.
Southwood Research is a leading provider of pre-approval regulatory science services to the pharmaceutical and biotech industries. "We are thrilled about our future as a part of ProPharma Group. The combination expands our global reach, as well as our ability to provide end-to-end services for our clients within regulatory affairs," said Colin Wheeler, Vice President European Regulatory Affairs at Southwood Research.
Andy Coghlan, Head of Private Equity and International Transactions at Azets commented, "We are delighted to have advised Colin on this transaction and believe he has an ideal partner in ProPharma Group to continue the rapid growth of Southwood".
Whether you know what you need or just want to explore your options, we're here to help.
